Safety and Side Effects Common Side Effects Gastrointestinal upset (vomiting, diarrhea) Decreased appetite Mild hypoglycemia in diabetic animals Serious Risks Pancreatitis (rare) Allergic reactions Injection site reactions Precautions Use with caution in animals with a history of pancreatitis Avoid in pregnant or lactating animals unless approved Always use under veterinary supervision Future Perspectives and Research The promising results seen in early trials suggest that Semaglutide could become a mainstay in veterinary weight management and diabetes treatment
GLP-1 RAs mimic the action of glucagon-like peptide-1 to suppress appetite and delay gastric emptying
Diagnosis of Hashimotos thyroiditis primarily relies on serological tests to detect elevated levels of thyroid antibodies, alongside assessments of thyroid hormone levels, particularly Thyroid Stimulating Hormone (TSH) and Free Thyroxine (T4)
Common potential side effects of Semaglutide include nausea, vomiting, diarrhea, and rare instances of muscle loss
Shooting directly onto the peptide can create foam and mechanically stress the protein structure
Further research is required to investigate the effect of semaglutide treatment on fatty liver, alcohol use disorder and fertility
